Welcome, Guest

Markets

 
Equity
You are in News
News Equity Commentary ResultsMarket Performance Announcement Other Announcement Todays Board Meetings Forth coming board Meetings Book Closure ADR Prices Name Changes News Ticker De-listed Companies Sectorial Indices FII Activity [Cr] Global Indices Knowledge Center
Jan 25 2010
Fresenius Kabi Oncology appoints director

The board of Fresenius Kabi Oncology in its meeting on 20 January 2010 has appointed Mats Christer Henriksson as director of the company with effect from 20 January 2010.

Powered by Capital Market - Live News

  Source:   
  Capital markets Disclaimer
  Mutual fund partners
  

Company Search




Copyright©2009. All rights Reserved.
Equities: Equities transactions executed by Reliance Securities Limited | NSE SEBI Registration Number Capital Market :- INB 231234833 | BSE SEBI Registration Number Capital Market :- INB 011234839 | NSE SEBI Registration Number Derivatives :- INF 231234833 | Mutual Funds : Reliance Securities Limited | AMFI ARN No.29889
In case of any grievances please write to customer.grievance@reliancemoney.co.in
This site is best viewed in 1024x768 and higher resolution.